Cipher Pharmaceuticals Inc. (TSX:CPH)

Cipher Pharmaceuticals Revenue

Cipher Pharmaceuticals had revenue of $12.07M USD in the quarter ending June 30, 2026, a decrease of -9.82%. This brings the company's total for the last twelve months to $49.62M, up 4.27% year-over-year. In the year 2025, Cipher Pharmaceuticals had annual revenue of $50.45M with 51.22% growth. That makes Cipher Pharmaceuticals the 27,936th largest company in the world by revenue and 511th in Canada.

• Revenue (ttm): $49.62M
• Revenue Growth: +4.27%
• P/S Ratio: 4.87
• Revenue / Employee: $9.92M
• Employees: 5
• Market Cap: 331.67M CAD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Geography

Chart

• United States (U.S.) 33.54M 66.5%
• Canada 16.91M 33.5%

Fiscal year ended Dec 31, 2025 See the full Cipher Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	50.45M	17.09M	51.22%
Dec 31, 2024	33.36M	12.20M	57.66%
Dec 31, 2023	21.16M	487.00K	2.36%
Dec 31, 2022	20.68M	-1.27M	-5.78%
Dec 31, 2021	21.94M	336.00K	1.56%
Dec 31, 2020	21.61M	-844.00K	-3.76%
Dec 31, 2019	22.45M	-298.00K	-1.31%
Dec 31, 2018	22.75M	-17.39M	-43.33%
Dec 31, 2017	40.14M	10.49M	35.38%
Dec 31, 2016	29.65M	-4.76M	-13.83%
Dec 31, 2015	34.41M	5.19M	17.74%
Dec 31, 2014	29.22M	3.83M	15.08%
Dec 31, 2013	25.39M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error